Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first therapy for severe equine asthma – Business Wire

Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first therapy for severe equine asthma  Business Wire

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.